References
- Gronberg H. Prostate cancer epidemiology. Lancet 2003;361:859-64.
- Tammela TL. Endocrine prevention and treatment of prostate cancer. Mol Cell Endocrinol 2012;360:59-67. https://doi.org/10.1016/j.mce.2012.03.002
- Quinn DI, Henshall SM, Sutherland RL. Molecular markers of prostate cancer outcome. Eur J Cancer 2005;41:858-87. https://doi.org/10.1016/j.ejca.2004.12.035
- Petrylak DP. The current role of chemotherapy in metastatic hormonerefractory prostate cancer. Urology 2005;65:3-7. discussion 7-8. https://doi.org/10.1016/j.urology.2005.03.053
- Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9:259-74.
- Jin X, Che DB, Zhang ZH, Yan HM, Jia ZY, Jia XB. Ginseng consumption and risk of cancer: a meta-analysis. J Ginseng Res 2016;40:269-77. https://doi.org/10.1016/j.jgr.2015.08.007
- Yun TK. Experimental and epidemiological evidence on nonorgan specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 2003;523:63-74.
- Nag SA, Qin JJ, Wang W, Wang MH, Wang H, Zhang R. Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action. Front Pharmacol 2012;3:25.
- O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998;7:523-36. https://doi.org/10.1001/archfami.7.6.523
- Xie JT, Wang CZ, Wang AB, Wu J, Basila D, Yuan CS. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng. Acta Pharmacol Sin 2005;26:1104-10. https://doi.org/10.1111/j.1745-7254.2005.00156.x
- Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 2001;16:S28-37. https://doi.org/10.3346/jkms.2001.16.S.S28
- Kitts D, Hu C. Efficacy and safety of ginseng. Public Health Nutr 2000;3:473-85.
- Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
- Wang Z, Zheng Q, Liu K, Li G, Zheng R. Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin Pharmacol Toxicol 2006;98:411-5.
- Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol Pharm Bull 1994;17:635-9.
- Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, Kudoh K, Nagata I, Shinomiya N. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Cancer Sci 1998;89:733-40.
- Zhao Y, Wang W, Han L, Rayburn ER, Hill DL, Wang H, Zhang R. Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng. Med Chem 2007;3:51-60. https://doi.org/10.2174/157340607779317508
- Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 2007;59:589-601.
- Wang W, Rayburn ER, Zhao Y, Wang H, Zhang R. Novel ginsenosides 25-OHPPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action. Cancer Lett 2009;278:241-8. https://doi.org/10.1016/j.canlet.2009.01.005
- Wang P, Bi XL, Xu J, Yuan HN, Piao HR, Zhao YQ. Synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol analogs incorporating natural amino acids. Steroids 2013;78:203-9.
- Qu FZ, Liu YF, Cao JQ, Wang XD, Zhang XS, Zhao C, Zhao YQ. Novel 25-hydroxyprotopanaxadiol derivatives incorporating chloroacetyl chloride and their anti-tumor evaluation. Bioorg Med Chem Lett 2014;24:5390-4. https://doi.org/10.1016/j.bmcl.2014.10.050
- Adams JM, Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 2007;19:488-96. https://doi.org/10.1016/j.coi.2007.05.004
- Hou Q, Cymbalyuk E, Hsu SC, Xu M, Hsu YT. Apoptosis modulatory activities of transiently expressed Bcl-2: roles in cytochrome C release and Bax regulation. Apoptosis 2003;8:617-29. https://doi.org/10.1023/A:1026187526113
- Gu X, Yao Y, Cheng R, Zhang Y, Dai Z, Wan G, Yang Z, Cai W, Gao G, Yang X. Plasminogen K5 activates mitochondrial apoptosis pathway in endothelial cells by regulating Bak and Bcl-x(L) subcellular distribution. Apoptosis 2011;16:846-55. https://doi.org/10.1007/s10495-011-0618-9
- Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol 2008;414:13-21.
- Wade M, Wong ET, Tang M, Stommel JM, Wahl GM. Hdmx modulates the outcome of p53 activation in human tumor cells. J Biol Chem 2006;281:33036-44. https://doi.org/10.1074/jbc.M605405200
- Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992;358:80-3. https://doi.org/10.1038/358080a0
- Moungjaroen J, Nimmannit U, Callery PS, Wang L, Azad N, Lipipun V, Chanvorachote P, Rojanasakul Y. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J Pharm Exp Ther 2006;319:1062-9.
- Yang ES, Woo SM, Choi KS, Kwon TK. Acrolein sensitizes human renal cancer Caki cells to TRAIL-induced apoptosis via ROS-mediated up-regulation of death receptor-5 (DR5) and down-regulation of Bcl-2. Exp Cell Res 2011;317:2592-601. https://doi.org/10.1016/j.yexcr.2011.08.005
- Luo M, Liu X, Zu Y, Fu Y, Zhang S, Yao L, Efferth T. Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway. Chem Biol Interact 2010;188:151-60. https://doi.org/10.1016/j.cbi.2010.07.009
- Baarsma HA, Konigshoff M, Gosens R. The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets. Pharmacol Ther 2013;138:66-83. https://doi.org/10.1016/j.pharmthera.2013.01.002
- Kypta RM, Waxman J. Wnt/beta-catenin signalling in prostate cancer. Nat Rev Urol 2012;9:418-28.
Cited by
- Antineoplastic Activity, Structural Modification, Synthesis and Structure-activity Relationship of Dammarane-type Ginsenosides: An Overview vol.23, pp.5, 2019, https://doi.org/10.2174/1385272823666190401141138
- Betulinic Acid Suppresses Ovarian Cancer Cell Proliferation through Induction of Apoptosis vol.9, pp.7, 2018, https://doi.org/10.3390/biom9070257
- Absolute Configuration and Corrected NMR Assignment of 17-Hydroxycyclooctatin, a Fused 5-8-5 Tricyclic Diterpene vol.83, pp.2, 2018, https://doi.org/10.1021/acs.jnatprod.9b00837
- Calvatianone, a Sterol Possessing a 6/5/6/5-Fused Ring System with a Contracted Tetrahydrofuran B-Ring, from the Fruiting Bodies of Calvatia nipponica vol.83, pp.9, 2018, https://doi.org/10.1021/acs.jnatprod.0c00673